Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
- PMID: 11157179
- DOI: 10.1161/01.str.32.2.438
Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)
Abstract
Background and purpose: Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) improves the outcome for ischemic stroke patients who can be treated within 3 hours of symptom onset. The efficacy of thrombolysis has been demonstrated despite an increased risk of severe hemorrhagic transformation (HT) in patients treated with rtPA. We performed an analysis of risk factors for severe HT in the second European-Australasian Acute Stroke Study (ECASS II).
Methods: HTs were classified by using clinical and radiological criteria as follows: hemorrhagic infarction (HI), parenchymal hemorrhage (PH), and symptomatic intracranial hemorrhage (SICH). Potential risk factors for HT were tested by stepwise logistic regression analysis, including rtPA-by-variable interactions. In addition, the distribution of bad outcome (modified Rankin score 5 to 6) at day 90 was stratified according to each category of HT.
Results: PH and SICH but not HI were associated with rtPA. Also, PH and SICH but not HI were more severe in rtPA-treated patients than in those receiving placebo. Risk factors for PH were rtPA, extent of parenchymal hypoattenuation on baseline CT, congestive heart failure, increasing age, and baseline systolic blood pressure. The risk of PH on rtPA was increased in older patients and in those who were treated with aspirin before thrombolysis. Risk factors for SICH were rtPA, congestive heart failure, extent of parenchymal hypoattenuation, and increasing age. The risk of SICH on rtPA was increased in patients who were treated with aspirin before thrombolysis.
Conclusions: This secondary analysis of ECASS II has confirmed the importance of the extent of hypoattenuation as a risk factor for severe HT. The findings also suggest that older patients and those who have used aspirin before stroke are at higher risk of a severe HT on rtPA.
Similar articles
-
Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104360. doi: 10.1016/j.jstrokecerebrovasdis.2019.104360. Epub 2019 Sep 14. J Stroke Cerebrovasc Dis. 2019. PMID: 31501036
-
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.
-
Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104363. doi: 10.1016/j.jstrokecerebrovasdis.2019.104363. Epub 2019 Sep 6. J Stroke Cerebrovasc Dis. 2019. PMID: 31501038
-
Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.Stroke. 2007 Feb;38(2):313-8. doi: 10.1161/01.STR.0000254565.51807.22. Epub 2007 Jan 4. Stroke. 2007. PMID: 17204683
-
Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.Cerebrovasc Dis. 2007;24(1):1-10. doi: 10.1159/000103110. Epub 2007 May 22. Cerebrovasc Dis. 2007. PMID: 17519538 Review.
Cited by
-
The Stress Hyperglycemia Ratio is Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke.Clin Interv Aging. 2021 Mar 9;16:431-442. doi: 10.2147/CIA.S280808. eCollection 2021. Clin Interv Aging. 2021. PMID: 33727806 Free PMC article.
-
Initial 'TTP Map-Defect' of Computed Tomography Perfusion as a Predictor of Hemorrhagic Transformation of Acute Ischemic Stroke.Cerebrovasc Dis Extra. 2013 Feb 13;3(1):14-25. doi: 10.1159/000346113. Print 2013 Jan. Cerebrovasc Dis Extra. 2013. PMID: 23637697 Free PMC article.
-
Potential for the use of the Solitaire stent for recanalization of middle cerebral artery occlusion without a susceptibility vessel sign.AJNR Am J Neuroradiol. 2014 Jan;35(1):149-55. doi: 10.3174/ajnr.A3562. Epub 2013 Jun 6. AJNR Am J Neuroradiol. 2014. PMID: 23744693 Free PMC article. Clinical Trial.
-
Long-term outcomes of post-thrombolytic intracerebral hemorrhage in ischemic stroke patients.Neurocrit Care. 2013 Apr;18(2):170-7. doi: 10.1007/s12028-012-9803-0. Neurocrit Care. 2013. PMID: 23212243 Clinical Trial.
-
A novel nomogram to predict hemorrhagic transformation in ischemic stroke patients after intravenous thrombolysis.Front Neurol. 2022 Sep 8;13:913442. doi: 10.3389/fneur.2022.913442. eCollection 2022. Front Neurol. 2022. PMID: 36158944 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials